Your browser doesn't support javascript.
loading
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 study.
Hua, Rui; Kong, Fei; Wen, Xiaofeng; Xiong, Qingfang; Chen, Jiayu; Meng, Chenxin; Ma, Hong; Tan, Youwen; Huang, Yan; Jiang, Yongfang; Guan, Yujuan; Mao, Xiaorong; Wang, Jiefei; Xin, Yongning; Gao, Hainv; Xu, Bin; Li, Cheng; Wu, Qiong; Zhang, Xian; Wang, Zhiqiang; Zhao, Liwen; Zhang, Yuexin; Li, Guangming; Niu, Junqi.
Afiliação
  • Hua R; The First Hospital of Jilin University, Changchun, China.
  • Kong F; The First Hospital of Jilin University, Changchun, China.
  • Wen X; Liuzhou People's Hospital, Liuzhou, China.
  • Xiong Q; The Second Hospital of Nanjing, Nanjing, China.
  • Chen J; The 940th Hospital of Joint Logistics Support Force of PLA, Lanzhou, China.
  • Meng C; The Sixth People's Hospital of Shenyang, Shenyang, China.
  • Ma H; Beijing Friendship Hospital Affiliated with Capital Medical University, Beijing, China.
  • Tan Y; The Third People's Hospital of Zhenjiang, Zhenjiang, China.
  • Huang Y; Xiangya Hospital, Central South University, Changsha, China.
  • Jiang Y; The Second Xiangya Hospital of Central South University, Changsha, China.
  • Guan Y; Guangzhou Eighth People's Hospital, Guangzhou, China.
  • Mao X; The First Hospital of Lanzhou University, Lanzhou, China.
  • Wang J; Shanghai Public Health Clinical Center, Shanghai, China.
  • Xin Y; Qingdao Municipal Hospital, Qingdao, China.
  • Gao H; Shulan (Hangzhou) Hospital, Hangzhou, China.
  • Xu B; Beijing You'an Hospital Affiliated with Capital Medical University, Beijing, China.
  • Li C; Zhengzhou Sixth People's Hospital, Zhengzhou, China.
  • Wu Q; Nanjing Sanhome Pharmaceutical Co., Ltd, Nanjing, China.
  • Zhang X; Nanjing Sanhome Pharmaceutical Co., Ltd, Nanjing, China.
  • Wang Z; Nanjing Sanhome Pharmaceutical Co., Ltd, Nanjing, China.
  • Zhao L; Nanjing Sanhome Pharmaceutical Co., Ltd, Nanjing, China.
  • Zhang Y; The First Hospital Affiliated to Xinjiang Medical University, Urumchi, China.
  • Li G; Zhengzhou Sixth People's Hospital, Zhengzhou, China.
  • Niu J; The First Hospital of Jilin University, Changchun, China.
J Viral Hepat ; 29(6): 455-464, 2022 06.
Article em En | MEDLINE | ID: mdl-35080256
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepacivirus / Hepatite C Crônica Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepacivirus / Hepatite C Crônica Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido